We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Drug Target for Ewing Sarcoma Identified

News   Jan 29, 2018 | Original story from Boston Children's Hospital

 
Drug Target for Ewing Sarcoma Identified

Infographic showing how PARP and CDK12 inhibition lead to deficient DNA damage repair and cell death in Ewing sarcoma cells. Credit: Dana-Farber/Boston Children's Cancer and Blood Disorders Center

 
 
 

RELATED ARTICLES

Progress in Cochlear Regeneration

News

This research demonstrates a signaling pathway that can be activated by different methods and could represent a new approach to cochlear regeneration and, ultimately, restoration of hearing.

READ MORE

Ancient Enzymes the Catalysts for Discoveries

News

University of Queensland-led research recreating 450 million-year-old enzymes has resulted in a biochemical engineering ‘hack’ which could lead to new drugs, flavours, fragrances and biofuels.

READ MORE

Drug Cocktail Could Increase Lifespan

News

A team of researchers has discovered a combination of pharmaceutical drugs that not only increases healthy lifespan in the microscopic worm Caenorhabditis elegans (C. elegans), but also delays the rate of ageing in them, a finding that could someday mean longer, healthier lives for humans.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Cancer Research

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE